Literature DB >> 7504073

Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection.

H Okamoto1, H Tokita, M Sakamoto, M Horikita, M Kojima, H Iizuka, S Mishiro.   

Abstract

We have identified four new hepatitis C virus (HCV) isolates whose genomic RNA could be amplified by PCR using primers from the 5' untranslated region (UTR), but the RNA could not be detected with genotype I to IV (or types 1a, 1b, 2a and 2b respectively)-specific core region-derived primers. We compared the nucleotide sequences of the new isolates from positions 65 to 1850 (3' end of 5' UTR, C, E1 and 5' end of E2/NS1) and 8276 to 9394 (3' end of NS5 and 3' UTR) with those for genotypes I to IV. The four isolates had the following characteristics: (i) the overall nucleotide sequence similarity between the four isolates was 95 to 96%, compared to 73 to 74%, 73%, 70% or 69 to 70% against genotypes I, II, III or IV, respectively; (ii) the sequence similarity to other reported 'type V (3a)' isolates was 88 to 100%; (iii) the hypervariable region 1 [(HVR)-1] was present but HVR-2 was absent within the E2/NS1 region; (iv) only one in-frame termination codon was present for the presumed polyprotein; (v) the 3'UTR preceding a terminal poly(U) stretch was significantly shorter than in genotype I to IV isolates. We classified the four isolates as genotype V (3a), and searched for uniquely conserved nucleotide sequences that could be used for type-specific PCR. A core region-derived primer pair (no. 104V: 5' CGTAAAACTTCT GAACGGTC, sense and no. 339: 5' GCTGAGCCCA GGACCGGTCT, antisense) was identified and successfully used to diagnose genotype V (3a) HCV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504073     DOI: 10.1099/0022-1317-74-11-2385

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  78 in total

1.  High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.

Authors:  Louisa A Jones; Leighton E Clancy; William D Rawlinson; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio.

Authors:  S Mihm; H Hartmann; A Fayyazi; G Ramadori
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

3.  Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes.

Authors:  L Stuyver; W van Arnhem; A Wyseur; F Hernandez; E Delaporte; G Maertens
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

4.  Subtyping of hepatitis C virus isolates by a line probe assay using hybridization.

Authors:  A Andonov; R K Chaudhary
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

Review 5.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Comparative evaluation of two serologic typing methods for hepatitis C virus.

Authors:  A Cerino; A Cividini; M Asti; A Lanza; E Silini; M U Mondelli
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

7.  Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay.

Authors:  S Navas; I Castillo; J Martín; J A Quiroga; J Bartolomé; V Carreño
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

8.  Prevalence of hepatitis C virus genotypes in southern Italy.

Authors:  S Cicciarello; G Borgia; J Crowell; R Ciampi; R Cerini; R Orlando; M Mainolfi; L Reynaud; M Milano; M Piazza
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

9.  Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis.

Authors:  Perdita Wietzke-Braun; Felix Braun; Burckhart Sattler; Giuliano Ramadori; Burckhardt Ringe
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

10.  Cooperative oligonucleotides mediating direct capture of hepatitis C virus RNA from serum.

Authors:  D O'Meara; Z Yun; A Sönnerborg; J Lundeberg
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.